Parkinson's Disease clinical trials at UC Irvine
3 research studies open to new patients
A Study of LY3154207 in Participants With Parkinson's Disease Dementia
open to eligible people ages 40-85
A randomized placebo-controlled trial in individuals with Parkinson's disease dementia to evaluate the safety and efficacy of three doses of study drug LY3154207 in participants with mild-to-moderate Parkinson's disease dementia treated for 12 weeks.
Irvine, California and other locations
An Open-Label Phase 3 Study to Examine the Long-Term Safety, Tolerability and Efficacy of APL-130277 for the Acute Treatment of "OFF" Episodes in Patients With Parkinson's Disease
open to eligible people ages 18 years and up
An Open-Label Phase 3 Study to Examine the Long-Term Safety, Tolerability and Efficacy of APL-130277 for the Acute Treatment of "OFF" Episodes in Patients With Parkinson's Disease
Irvine, California and other locations
VY-AADC02 for Parkinson's Disease With Motor Fluctuations
open to eligible people ages 40-75
The objectives of this study are to assess the distribution, efficacy, and safety of VY-AADC02 in Patients with Parkinson's Disease with Motor Fluctuations.
Irvine, California and other locations
Last updated: